financing
In Brief This Week: Exagen; Quest Diagnostics; Oncocyte; Prevencio
News items for the week of May 12, 2025.
MiRxes Launches HK$880.5M IPO on Hong Kong Stock Exchange
The Singaporean company said it will use the proceeds to support commercialization of its gastric cancer test, further assay development, and other business purposes.
Liquid Biopsy Firm QCDx Closes $7M Financing Round
The proceeds will be used to launch a new diagnostic instrument, a breast cancer monitoring assay, and proprietary multiplex immunofluorescence reagent kits.
Spain's DeepUll Raises €50M in Oversubscribed Series C Financing Round
The funds will help the company finalize clinical trials for its automated molecular rapid sepsis pathogen identification and antimicrobial susceptibility testing system.
Craif Raises $22M in Series C Round to Expand US, Japan Operations
The Nagoya University spinout will open an office in San Diego and is working toward FDA approval of its miSignal early cancer detection test.
Mar 26, 2025
VolitionRx Prices $2.3M Registered Direct Offering
Feb 19, 2025
Tempus AI Raises $300M in Debt Financing
Feb 10, 2025
Oncocyte Enters $29.1M Securities Purchase Agreement
Nov 26, 2024
Nov 22, 2024
OneCell Diagnostics Raises $16M in Series A Round
Nov 5, 2024
PrognomiQ Closes $34M Series D Round
Oct 10, 2024